| T cell-based immunotherapy of metastatic renal cell carcinoma: Modest success ... - UroToday |
|
|
UroTodayMetastatic renal cell carcinoma (MRCC) remains a challenging malignancy to treat. Cancer immunotherapies have been extensively explored in melanoma and RCC ... read more |